Kelly Kearney
Director, Investor Relations and Communications
Daniel brings over 20 years of experience in entrepreneurship, venture building, and early-stage investment to Psy’s Board of Directors. As co-Founder and Managing Director at WPSS Investments, a venture capital firm focused on biotechnology and mental health, Daniel works to find solutions for the most complex and pressing issues in neuropsychiatry and neurodegeneration.
Prior to founding WPSS, Daniel served as co-Founder and CEO of GWEP, a boutique real estate development company that builds affordable housing options in underserved areas of Mexico City. Daniel holds an engineering degree from UIA and an MBA from the University of Wisconsin-Madison.